Lasa Supergenerics Q4 Results Live : loss rise by 1.92% YOY
Lasa Supergenerics Q4 Results Live : Revenue decreased by 35.41% YoY & loss increased by 1.92% YoY
Stay updated with breaking news from Lasa Supergenerics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lasa Supergenerics Q4 Results Live : Revenue decreased by 35.41% YoY & loss increased by 1.92% YoY
The Favipiravir Market is transforming the pharmaceutical sector, offering innovative and efficient solutions for viral infections.
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2023" report has been...
/PRNewswire/ -- The potassium iodide market is estimated to grow by USD 267.11 million from 2022 to 2027. The growth momentum will progress at a CAGR of 5.36%...
Lasa Supergenerics Limited, India Leading API Manufacturer, announced that it has secured a new order of Rs 500 Million from just 5 customers.